Loading…
Underlying
Underlying Price
$8.36
Type
Put
Strike
9.5
Expiration
Nov 27, 2026
DTE
38d
Moneyness
ITM
Intrinsic
$1.14
IBRX 9.5 Put Across Expirations
| Expiration | DTE | Last | Change | Vol | Open Int |
|---|---|---|---|---|---|
| Oct 23, 2026 | 3d | $0.55 | +83.33% | 76 | 438 |
| Oct 30, 2026 | 10d | $0.75 | +50.00% | 39 | 300 |
| Nov 6, 2026 | 17d | $1.10 | +48.65% | 2 | 80 |
| Nov 13, 2026 | 24d | $1.14 | +26.67% | 20 | 24 |
| Nov 27, 2026 | 38d | $1.13 | +7.62% | 1 | 17 |
IBRX Profile
immunitybio is a leading registration-stage immuno-oncology and infectious disease company activating both the innate (natural killer cell and macrophage) and adaptive (t cell) immune system. we are developing molecular and product platforms including n-803, aldoxorubicin, and a second-generation adenovirus vector, which are based upon our three key modalities of activating natural killer ('nk') and t cells, tumoricidal macrophages, and memory t cells.